DutchNews, October 29, 2015
Flevoland provincial council is investing
€1.5m in a company which aims to register medicinal marijuana as a medicine
against chronic pain, the Financieele Dagblad says on Thursday.
A full meeting
of the council voted in favour of the capital injection on Wednesday night, the
paper says.
The company, Spirocan, is working on a vapourisation system
involving cannabis-impregnated pads. That process should be completed next year,
when the company will move on to clinical trials on patients, company spokesman
Pieter Andre de la Porte told the paper.
‘Cannabis is already widely used and
it is known to work, including via a vapouriser,’ De la Porte said. ‘We are
improving something that already exists and that makes the process relatively
cheaper and easier.’
Many other companies have tried to have cannabis
registered as an official medicine and failed, the FD points out. ‘They have
tried it with pills and sprays,’ De la Porte said. ‘But that involves more
processing and you lose some of the effect. Vapourising is a much more pure
form.’
The Netherlands first approved medicinal marijuana several years ago and
licenced producer Bedrocan is part owner of Spirocan.
The company says it needs
total investment of €10m to develop the vapouriser.
According to local
broadcaster Omroep Flevoland, the investment will lead to the creation of
several dozen jobs. However, it is not yet clear in which part of the province
Spirocan will locate.
The province earlier gave the company an
investment of €150,000.
Related Articles:

No comments:
Post a Comment
Note: Only a member of this blog may post a comment.